| Impact of direct acting antiviral therapy in patients with chronic hepatitis C and decompensated cirrhosis GR Foster, WL Irving, MCM Cheung, AJ Walker, BE Hudson, S Verma, ... Journal of hepatology 64 (6), 1224-1231, 2016 | 580 | 2016 |
| Outcomes after successful direct-acting antiviral therapy for patients with chronic hepatitis C and decompensated cirrhosis MCM Cheung, AJ Walker, BE Hudson, S Verma, J McLauchlan, ... Journal of hepatology 65 (4), 741-747, 2016 | 460 | 2016 |
| Influenza virus infection in the second and third trimesters of pregnancy: a clinical and seroepidemiological study WL Irving, DK James, T Stephenson, P Laing, C Jameson, JS Oxford, ... BJOG: An International Journal of Obstetrics & Gynaecology 107 (10), 1282-1289, 2000 | 319 | 2000 |
| Apolipoprotein E-ε4 protects against severe liver disease caused by hepatitis C virus MA Wozniak, RF Itzhaki, BE Faragher, MW James, SD Ryder, WL Irving Hepatology 36 (2), 456-463, 2002 | 229 | 2002 |
| Clinical relapses and disease activity on magnetic resonance imaging associated with viral upper respiratory tract infections in multiple sclerosis S Edwards, M Zvartau, H Clarke, W Irving, LD Blumhardt Journal of Neurology, Neurosurgery & Psychiatry 64 (6), 736-741, 1998 | 216 | 1998 |
| Enhanced Liver Fibrosis (ELF) test accurately identifies liver fibrosis in patients with chronic hepatitis C J Parkes, IN Guha, P Roderick, S Harris, R Cross, MM Manos, W Irving, ... Journal of viral hepatitis 18 (1), 23-31, 2011 | 215 | 2011 |
| aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis R Fan, G Papatheodoridis, J Sun, H Innes, H Toyoda, Q Xie, S Mo, ... Journal of Hepatology 73 (6), 1368-1378, 2020 | 207 | 2020 |
| Interferon-λ rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease M Eslam, AM Hashem, R Leung, M Romero-Gomez, T Berg, GJ Dore, ... Nature communications 6 (1), 6422, 2015 | 177 | 2015 |
| Association between MHC class II alleles and clearance of circulating hepatitis C virus EJ Minton, D Smillie, KR Neal, WL Irving, JCE Underwood, V James, ... Journal of Infectious Diseases 178 (1), 39-44, 1998 | 176 | 1998 |
| Guillain–Barré syndrome variant occurring after SARS‐CoV‐2 vaccination CM Allen, S Ramsamy, AW Tarr, PJ Tighe, WL Irving, R Tanasescu, ... Annals of neurology 90 (2), 315-318, 2021 | 163 | 2021 |
| Virus Infertion WL Irving, S Day, I Johnston Am Rev Respir Dis 148, 1683-1684, 1993 | 154 | 1993 |
| Direct ex vivo comparison of the breadth and specificity of the T cells in the liver and peripheral blood of patients with chronic HCV infection AM Grabowska, F Lechner, P Klenerman, PJ Tighe, S Ryder, JK Ball, ... European journal of immunology 31 (8), 2388-2394, 2001 | 152 | 2001 |
| Excess mortality rates in a cohort of patients infected with the hepatitis C virus: a prospective study KR Neal Gut 56 (8), 1098-1104, 2007 | 146 | 2007 |
| A comprehensive study of the association between hepatitis C virus and glomerulopathy AA Sabry, MA Sobh, WL Irving, A Grabowska, BE Wagner, S Fox, ... Nephrology Dialysis Transplantation 17 (2), 239-245, 2002 | 136 | 2002 |
| IL28B, HLA-C, and KIR Variants Additively Predict Response to Therapy in Chronic Hepatitis C Virus Infection in a European Cohort: A Cross-Sectional Study V Suppiah, S Gaudieri, NJ Armstrong, KS O'Connor, T Berg, M Weltman, ... PLoS medicine 8 (9), e1001092, 2011 | 134 | 2011 |
| Hepatitis E: an emerging infection in high income countries JE Arends, V Ghisetti, W Irving, HR Dalton, J Izopet, AIM Hoepelman, ... Journal of Clinical Virology 59 (2), 81-88, 2014 | 133 | 2014 |
| Development of a strand-specific RT-PCR based assay to detect the replicative form of hepatitis C virus RNA JK Craggs, JK Ball, BJ Thomson, WL Irving, AM Grabowska Journal of virological methods 94 (1-2), 111-120, 2001 | 131 | 2001 |
| TT virus sequence heterogeneity in vivo: evidence for co-infection with multiple genetic types JK Ball, R Curran, S Berridge, AM Grabowska, CL Jameson, BJ Thomson, ... Journal of General Virology 80 (7), 1759-1768, 1999 | 125 | 1999 |
| MBOAT7 rs641738 increases risk of liver inflammation and transition to fibrosis in chronic hepatitis C K Thabet, A Asimakopoulos, M Shojaei, M Romero-Gomez, A Mangia, ... Nature communications 7 (1), 12757, 2016 | 122 | 2016 |
| HCV treatment rates and sustained viral response among people who inject drugs in seven UK sites: real world results and modelling of treatment impact NK Martin, GR Foster, J Vilar, S Ryder, M E. Cramp, F Gordon, JF Dillon, ... Journal of viral hepatitis 22 (4), 399-408, 2015 | 121 | 2015 |
